Regeneron Pharmaceuticals logo

Senior Director, Quality

Regeneron Pharmaceuticals

Saratoga Springs, NYOnsitePosted 1 day ago$207,000.00 - $407,400.00
Full TimeDirector & AboveQuality (QA / QC)Biotechnology
Original posting ↗

Summary

Regeneron is hiring a Sr. Director/Executive Director of Quality for a new highly automated bulk/drug substance manufacturing plant, supporting 20–30 tech transfers a year alongside commercial delivery responsibility. GMP production will run concurrently with construction and CQV for 3–5 years. This role requires both building and operating.

Job description

Discover your role

  • Own the site quality system (both QA & QC) and lead a culture of compliance, accountability, and right-first-time execution
  • QA: ops, systems, and validation owned directly alongside QC as part of a unified site quality organization
  • QC: responsible for delivering utilities, in-process and release testing, performing environmental monitoring, QC laboratory compliance, and method transfer support that enable timely, compliant batch release
  • Oversee these functions OpEx and CapEx budget and roadmap
  • Serve as the primary party responsible for this function's alignment with the Global Center of Excellence (COE)
  • Ensure this function's metrics flow up and down through the MDI structure, connecting into the site's S&OP, AOP, and long-range planning cycles
  • Hold batch disposition authority, ensuring compliance and timely batch release
  • Own and manage all regulatory inspections ensuring the site is continuously inspection-ready and leading the site through regulatory agency inspections and customer and corporate audits
  • Serve as the site's primary conduit for quality metrics, quality system work, and quality strategy connecting site execution to enterprise quality's vision for best-in-class lean quality operations
  • Provide governance of laboratory investigations, deviations, and CAPA management across all quality sub-functions
  • Lead all aspects of batch record review and disposition support, floor quality presence, and deviation management for manufacturing for Saratoga Site
  • Lead all aspects of QMS administration, document control, training compliance, CAPA system administration, and audit readiness for Saratoga Site
  • Build and coordinate best-in-class validation programs process, cleaning, and equipment validation grounded in FDA's three-stage process validation lifecycle, EU Annex 15, ASTM E2500 risk-based qualification, and ICH Q8–Q11 Quality by Design principles tailored to large-molecule biotech manufacturing, including PPQ support for new suite introduction
  • Lead quality readiness for suites entering service, including validation, qualification, and quality system scale-up
  • Partner with manufacturing, technical services, technical operations, and supply chain as a core member of the site leadership team
  • Own quality's role in the digital and connected plant model, including electronic quality systems, review by exception, and data integrity by design
  • Build, coach, and retain a high-performing quality organization; establish high standards for performance management and accountability
  • Lead a gross margin improvement program and goal for this function, contributing to the site's overall margin performance
  • Own and manage the site's data governance program, including data integrity standards, data ownership and accountability, lifecycle controls, and periodic review
  • Own and manage the site's quality management maturity, including assessing current state against enterprise and industry benchmarks, setting the improvement roadmap, and driving measurable gains in quality system performance
  • Own and manage the site's contamination control strategy, including its design, governance, and day-to-day execution across facility, equipment, process, personnel, and materials, with ongoing trending and review of effectiveness

This role requires

  • B.S in Life Sciences, Engineering, or a related technical field
  • Sr. Director: 15+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality including 7+ years of progressive quality leadership
  • Executive Director: 18+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality experience including 7+ years of progressive quality leadership
  • Level will be determined based on experience
  • Experience with batch disposition and release decision-making in a GMP environment
  • Previous people leadership/supervisory experience

Requirements

  • B.S in Life Sciences, Engineering, or a related technical field
  • 15+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality (Sr. Director)
  • 18+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality (Executive Director)
  • 7+ years of progressive quality leadership
  • Experience with batch disposition and release decision-making in a GMP environment
  • Previous people leadership/supervisory experience

Benefits

  • Annual bonuses
  • Incentive plans
  • Equity awards
  • Pension or retirement benefits
  • 401(k) company match
  • Health and wellness programs
  • Fitness centers
  • Medical, Dental & Vision
  • Life and disability insurance
  • Paid time off
  • Family support benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.